Clinical trials

15

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

MFinity BE Pre-market Trial

The primary objective of this trial is to determine the implant survival at 1 year of follow up in a population of patients undergoing primary Total Hip Replacement with MFinity Collared Femoral stem and to test its non-inferiority compared to other cementless implant (as reported by the EPRD registry).

Participants needed: 95
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Medacta International SAUpdated: Jun 1, 2026
Eligibility criteria

Patients undergoing elective primary total hip arthroplasty for primary osteoart... [+3]

Not meeting the inclusion criteria. [+10]

Status: Recruiting

Clinical and Radiological Outcomes of Medacta Shoulder System FR

This is a post-marketing surveillance on Medacta Shoulder System

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: Sep 29, 2025Locations: 1
Eligibility criteria

Patients older than 18 years

Patients with malignant diseases (at the time of surgery) [+3]

Status: Recruiting

Clinical Utility and Gait Analysis of NextAR System AUS

This study titled "Does Personalised Soft Tissue Balance Data Improve Outcomes in Patients Undergoing Medially Stabilised Arthroplasty? A Prospective, Randomised Study Investigating the Clinical Utility of the NextAR navigation system (NextAR)" is a randomised, single blinded, prospective cohort study with the primary aim determine the clinical utility of the NextAR system data in providing soft tissue balance patterns to enable prosthesis implants to resemble more native knee alignment.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: Sep 29, 2025Locations: 1
Eligibility criteria

End-stage osteoarthritis of the knee suitable for total knee arthroplasty. [+1]

Unsuitable for TKR due to chronic infection, medical disease, inability to conse... [+5]

Status: Recruiting

Multicenter Mpact DM France

The primary objective of the study is to evaluate the 10-year performance of the MPACT DM cup in the treatment of patients requiring total hip arthroplasty. The primary endpoint is the 10-year life span of the prosthesis according to the Kaplan Meier curve.

Participants needed: 600
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: Sep 29, 2025Locations: 1
Eligibility criteria

Patient with a disease that meets the indications for use of Medacta implants (a... [+4]

Patient requiring a transplant [+11]

Status: Recruiting

The Medacta GMK SpheriKA Post-Marketing Surveillance Study

This is a Post-Marketing Surveillance of GMK SpheriKA knee stem prosthesis.

Participants needed: 281
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: Sep 29, 2025Locations: 4
Eligibility criteria

Patients willing to sign the informed consent. [+4]

Patients with inflammatory arthritis. [+9]

Status: Recruiting

The Medacta International SMS Post-Marketing Surveillance Study

This is a Post-Marketing Surveillance of SMS femoral stem prosthesis.

Participants needed: 550
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: Sep 29, 2025Locations: 4
Eligibility criteria

Individuals with a severely painful and/or disabling hip joint with osteoarthrit... [+2]

Active infection [+11]

Status: Recruiting

Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System

The goal of this observational study is to collect clinical and radiological data to monitor the safety and performance of the ROMAX hip resurfacing system. The main parameter that will be measured is the rate of revisions at 10 years.

Participants needed: 150
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: Sep 25, 2025Locations: 1
Eligibility criteria

Patients eligible for hip resurfacing, suitable for the implantation of a Medact... [+2]

Active infection [+11]

Status: Recruiting

Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty

The goal of this randomized, controlled, monocentric, single-blind, 2-arm, feasibility clinical investigation is to evaluate the safety of MectaShield hydrogel coating and to capture its preliminary clinical performance in the prevention of early peri-prosthetic joint infection (PJI) in patients undergoing cementless revision hip arthroplasty. The main questions it aims to answer are: * demonstrate that the hydrogel coating MectaShield does not interfere with primary stability; * evaluate clinical and functional outcomes, the rate of PJI and possible adverse events. Participants will undergo cementless revision hip arthroplasty; during surgery MectaShield hydrogel coating is applied on orthopaedic implants' surfaces (femoral stem and, if revised, acetabular cup) as a protective barrier for the prevention of bacterial adhesion. Surgery and follow-up are completed as per local standard practice. Stability will be assessed radiologically, while functional outcomes and PJI will be monitored by HOOS-PS, ASESPIS scores and according to the consensus document presented by European Society of Radiology (ESRa), the European Association of Nuclear Medicine (EANM), the European Bone and Joint Infection Society (EBJIS), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Researchers will compare the results of the treatment group with those from a control group receiving cementless revision hip arthroplasty without the application of MectaShiled hydrogel coating.

Participants needed: 56
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Medacta International SAUpdated: May 11, 2025Locations: 1
Eligibility criteria

Informed Consent signed by the subject [+3]

Subjects with one or more medical conditions identified as a contraindication de... [+6]

Status: Recruiting

Mirror Medacta Shoulder System Pivotal Trial

The purpose of this study is to demonstrate safety and efficacy of the Mirror Medacta Shoulder System in total shoulder arthroplasty.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Medacta International SAUpdated: May 8, 2025Locations: 2
Eligibility criteria

Age ≥ 18 yr [+2]

Medical condition or balance impairment that could lead to falls [+17]

Status: Recruiting

Mpact 3D Metal Monolit Study

Total hip arthroplasty (THA) is one of the most common operations performed in orthopaedics to improve a patient's quality of life. Surgeons are constantly seeking to improve all aspects of care related to this procedure, whether it be improving implant technology, improving instrumentation or the technique involved in performing the procedure. In recent years, a new porous titanium coating has been introduced to promote good osseointegration of uncemented cups. High friction torque and a feeling of immediate anchorage provide excellent primary stability, while high porosity ensures bone growth providing secondary stability. With higher porosity than standard coatings, a greater volume of bone can be present in the porous surface, giving a proportional increase in force at the interface. he Mpact 3D Metal Monolith cup has been designed to provide greater range of motion and improved joint stability, with a reduced risk of dislocation. It is an innovative design that improves stability and provides a favourable environment for long-term biological metal-bone fixation. The current study aims to collect clinical and radiological data to assess the function of the operated hip and the stability of the Mpact 3D Metal Monolith cup at 2 years and survival at 5 years for the treatment of patients requiring hip arthroplasty.

Participants needed: 88
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: Dec 27, 2024Locations: 3
Eligibility criteria

Patient with a disease that corresponds to the indications for use of Medacta im... [+4]

Patient suffering from inflammatory arthritis [+6]

Status: Recruiting

Multicentre SMS Study - FR

Prospective, multicentre, non controled, non randomised, clinical study to assess the performance and the stability of SMS femoral stem

Participants needed: 260
Trial details
Age: 18-85Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: Oct 15, 2024Locations: 1
Eligibility criteria

Patient suffering from a severely painful and/or disabling hip joint due to oste... [+5]

Participation in biomedical research. [+16]

Status: Recruiting

A Post Market Surveillance Study About the MONOCER Cup

Over the years, the use of large diameter femoral heads has become increasingly common in orthopaedics due to the decreased risk of dislocation due to increased jumping distance and range of motion. The history of total hip arthroplasty does not favour large diameter heads, especially as conventional polyethylene has a high risk of wear. The development of hard-on-hard bearings (CoC) with a second generation ceramic material and the introduction of cross-linked PE have led to the reintroduction of this concept. The Mpact 3D Metal MonoCER cup was developed to offer the advantages of accommodating large diameter heads with an external metal cup with a pre-assembled system that avoids the surgical step of insert-cotile coupling.

Participants needed: 250
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: May 1, 2024Locations: 1
Eligibility criteria

Patients undergoing total hip arthroplasty who will receive the Mpact 3D Metal M... [+1]

Minor patients, patients over 75 years of age at the time of primary surgery; [+1]

Status: Recruiting

GMK Sphere TiNb Total Knee Arthroplasty PMS Study

Total knee arthroplasty (TKA) is one of the success stories of modern surgery, providing high patient satisfaction outcomes. Total knee prostheses are generally composed by a femoral component articulating on a polyethylene insert and a tibial tray. Recently there has been particular attention on the component material; traditionally femoral components are made of cobalt alloys while tibial baseplates are made, in the great majority of cases, of metallic materials, but also polyethylene versions are available. There has been a degree of acceptance in some countries that metal related pathology may exist as demonstrated by the Australian Arthroplasty register where metal hypersensitivity was reported as the fifth most common cause for revision hip arthroplasty 2012 report, making up for 5.9% of all revisions. The wording was subsequently changed from "metal sensitivity" to "metal related pathology" in the 2014 report with 0.5% of all revision total hip arthroplasties (THA) associated with this term. The same change in terminology was used for TKA with metal sensitivity as a cause for revision in 1.3% of revisions in 2012 and in 2014, 1.8% of revision TKAs attributed to "metal related pathology" . The overall revision rate was 3.45% after 10 years in 396.472 TKAs, suggesting a revision rate of 0.06-0.32% secondary to metal or cement allergies. Up to today there is no question that metallic implants may generate wear debris that cause local reactions. This local reaction is not dose related nor predictable and therefore not purely due to the toxic effect of the debris but possibly due to an immunological host process. Hypersensitivity to metal undoubtedly exists but it cannot be stated at the moment to be an allergic reaction. To prevent issues arising due to metal related pathology, alternative solutions to conventional chrome cobalt material have been proposed, for example ceramic component or implant coating. In particular, TiNbN coating has been proposed by most companies thanks to its excellent biological properties. Preclinical studies have showed a high scratch resistance and low coefficient of friction, more resistance to fretting corrosion, reduction of wear, lower ion release rates and low fatigue cycle, as described in the review of Hove. Clinically, cohort of studies of TiN-coated implants showed an overall survival exceeding 90% with a follow-up of 15 to 77 months and good clinical outcomes. No reports of adverse effects related to TiN coating of CoCrMo knee implants have been showed. There are few studies that compared TiN-coated implants with the same uncoated version. Thienpont, comparing TiN-coated and uncoated CoCrMo implants, showed similar clinical and radiological outcomes at short-term follow up in both patients groups . Overall we can conclude that in literature no adverse events have been reported concerning the TiNbN coating and in particular it has been showed that the coating doesn't not affect the performance of the device if compared with the same uncoated version. The aim of this study is to evaluate the long term clinical and radiological performance of GMK Sphere total knee component, coated version.

Participants needed: 155
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: May 1, 2024Locations: 1
Eligibility criteria

Those older than 18 years old at the surgery time [+2]

Those patients with metal implants containing Co, Cr and / or Ni [+4]

Status: Recruiting

Mpact 3D Metal Cup PMS

Cementless fixation, with or without screw augmentation, has evolved during the past few decades as the preferred method for acetabular reconstruction. Although major improvements have been recorded with regard to clinical outcomes and survivorship, acetabular component loosening remains among the most common causes of failure and revision. Patient age, poor bone quality and conditions, such as osteonecrosis and dysplasia, have been observed to influence negatively long-term clinical results. Initial stability is fundamental for survivorship of cementless cups. Prerequisites to achieve durable cementless cup fixation are close contact with viable native bone, primary mechanical stability and secondary bone integration. Press-fit techniques provide optimal conditions for bone ingrowth and fixation but research focused on cup material in order to improve primary stability. Pore size, bone-implant apposition, and material properties all influence bone ingrowth and long-term stability. Biological ingrowth surfaces have become a standard prosthetic element in reconstructive hip surgery. A material's properties, three-dimensional architecture, and surface texture all play integral parts in its biological performance. Trabecular metal is an important new biomaterial that has been introduced to enhance the potential of biological ingrowth as well as provide a structural scaffold in cases of severe bone deficit. The continuity between the porous and solid parts has been specifically developed to overcome the limitations of the traditional porous coatings. In fact, the absence of an interface between the trabecular structure and the bulk material provides greater structural solidity and thus higher resistance to detachment and corrosion. Initial clinical applications have focused on bone restoration in tumor and salvage cases and in primary and revision reconstructive cases where the increased biological fixation would be of clinical benefit. However the bone ingrowth potential and mechanical integrity of this material offer exciting options for orthopedic reconstructive surgeons such as difficult THA cases, such as patients with high demands, subjects affected by severe hip conditions (i.e. osteonecrosis, dysplasia) or with extremely poor bone quality. Medacta Mpact 3D Metal cup, is an acetabular cup realized using the EBM (Electron Beam Melting) powder technology; this production method offers a high friction and scratch-fit feel for the initial stability, without the need of any additional coating. Moreover the 3D Metal structure creates a favorable environment for bone thus providing secondary fixation. The aim of this study is to evaluate the long term clinical and radiological performance of MPact 3D Metal acetabular component.

Participants needed: 500
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: May 1, 2024Locations: 1
Eligibility criteria

Those suffering from hip primary arthrosis, post-traumatic arthrosis, hip dyspla... [+3]

Those with acute or chronic infection [+8]

Status: Recruiting

M-ARS ACL Post-marketing Surveillance Study

The goal of this study is to evaluate the performance of Medacta Anatomic Ribbon Surgery (M-ARS) in patients requiring anterior cruciate ligament (ACL) reconstruction. The main goal is to evaluate the survival rate of M-ARS ACL at 6 months post-operatively. The secondary goals are to assess the survival rate, clinical and functional outcomes, the quality of life, and the rate of complications at 1 month, 1 year and 2 years post-operatively.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Medacta International SAUpdated: Mar 13, 2023Locations: 3
Eligibility criteria

Patients older than 18 years [+1]

Patients with malignant diseases (at the time of surgery) [+3]